On the Addictive Power of Gabapentinoids: a Mini-Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Summary Analgesics Dec2019
Status as of December 31, 2019 UPDATE STATUS: N = New, A = Advanced, C = Changed, S = Same (No Change), D = Discontinued Update Emerging treatments for acute and chronic pain Development Status, Route, Contact information Status Agent Description / Mechanism of Opioid Function / Target Indication / Other Comments Sponsor / Originator Status Route URL Action (Y/No) 2019 UPDATES / CONTINUING PRODUCTS FROM 2018 Small molecule, inhibition of 1% diacerein TWi Biotechnology / caspase-1, block activation of 1 (AC-203 / caspase-1 inhibitor Inherited Epidermolysis Bullosa Castle Creek Phase 2 No Topical www.twibiotech.com NLRP3 inflamasomes; reduced CCP-020) Pharmaceuticals IL-1beta and IL-18 Small molecule; topical NSAID Frontier 2 AB001 NSAID formulation (nondisclosed active Chronic low back pain Phase 2 No Topical www.frontierbiotech.com/en/products/1.html Biotechnologies ingredient) Small molecule; oral uricosuric / anti-inflammatory agent + febuxostat (xanthine oxidase Gout in patients taking urate- Uricosuric + 3 AC-201 CR inhibitor); inhibition of NLRP3 lowering therapy; Gout; TWi Biotechnology Phase 2 No Oral www.twibiotech.com/rAndD_11 xanthine oxidase inflammasome assembly, reduced Epidermolysis Bullosa Simplex (EBS) production of caspase-1 and cytokine IL-1Beta www.arraybiopharma.com/our-science/our-pipeline AK-1830 Small molecule; tropomyosin Array BioPharma / 4 TrkA Pain, inflammation Phase 1 No Oral www.asahi- A (ARRY-954) receptor kinase A (TrkA) inhibitor Asahi Kasei Pharma kasei.co.jp/asahi/en/news/2016/e160401_2.html www.neurosmedical.com/clinical-research; -
About Pain Pharmacology: What Pain Physicians Should Know Kyung-Hoon Kim1, Hyo-Jung Seo1, Salahadin Abdi2, and Billy Huh2
Korean J Pain 2020;33(2):108-120 https://doi.org/10.3344/kjp.2020.33.2.108 pISSN 2005-9159 eISSN 2093-0569 Review Article All about pain pharmacology: what pain physicians should know Kyung-Hoon Kim1, Hyo-Jung Seo1, Salahadin Abdi2, and Billy Huh2 1Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Korea 2Department of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Received February 8, 2020 Revised March 12, 2020 From the perspective of the definition of pain, pain can be divided into emotional Accepted March 13, 2020 and sensory components, which originate from potential and actual tissue dam- age, respectively. The pharmacologic treatment of the emotional pain component Correspondence includes antianxiety drugs, antidepressants, and antipsychotics. The anti-anxiety Kyung-Hoon Kim drugs have anti-anxious, sedative, and somnolent effects. The antipsychotics are Department of Anesthesia and Pain effective in patients with positive symptoms of psychosis. On the other hand, the Medicine, Pusan National University sensory pain component can be divided into nociceptive and neuropathic pain. Yangsan Hospital, 20 Geumo-ro, Non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are usually applied for Mulgeum-eup, Yangsan 50612, Korea Tel: +82-55-360-1422 somatic and visceral nociceptive pain, respectively; anticonvulsants and antide- Fax: +82-55-360-2149 pressants are administered for the treatment of neuropathic pain with positive and E-mail: [email protected] negative symptoms, respectively. The NSAIDs, which inhibit the cyclo-oxygenase pathway, exhibit anti-inflammatory, antipyretic, and analgesic effects; however, they have a therapeutic ceiling. -
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
CLASSIFICATION DECISIONS TAKEN BY THE HARMONIZED SYSTEM COMMITTEE FROM THE 47TH TO 60TH SESSIONS (2011 - 2018) WORLD CUSTOMS ORGANIZATION Rue du Marché 30 B-1210 Brussels Belgium November 2011 Copyright © 2011 World Customs Organization. All rights reserved. Requests and inquiries concerning translation, reproduction and adaptation rights should be addressed to [email protected]. D/2011/0448/25 The following list contains the classification decisions (other than those subject to a reservation) taken by the Harmonized System Committee ( 47th Session – March 2011) on specific products, together with their related Harmonized System code numbers and, in certain cases, the classification rationale. Advice Parties seeking to import or export merchandise covered by a decision are advised to verify the implementation of the decision by the importing or exporting country, as the case may be. HS codes Classification No Product description Classification considered rationale 1. Preparation, in the form of a powder, consisting of 92 % sugar, 6 % 2106.90 GRIs 1 and 6 black currant powder, anticaking agent, citric acid and black currant flavouring, put up for retail sale in 32-gram sachets, intended to be consumed as a beverage after mixing with hot water. 2. Vanutide cridificar (INN List 100). 3002.20 3. Certain INN products. Chapters 28, 29 (See “INN List 101” at the end of this publication.) and 30 4. Certain INN products. Chapters 13, 29 (See “INN List 102” at the end of this publication.) and 30 5. Certain INN products. Chapters 28, 29, (See “INN List 103” at the end of this publication.) 30, 35 and 39 6. Re-classification of INN products. -
(ESRA) Congress 2018: E-Poster Viewing Abstracts
ABSTRACTS Abstracts and Highlight Papers of the 37th Annual European Society of Regional Anaesthesia & Pain Therapy (ESRA) 09/12/2018 on 1ojZViL9JnKxduCRhL/CcUAdyL6WwH5REYdVcwxqSc9xlxx/plvdjx0D6qkdcm/unXYqc/pwzsZMkY20jLisd3HCPQMoaMFxd03QOXvy15geUE+CR4J9Wp+ug9E5C+r4spJuQLeaJ8i4wLCpNFrgQgvjevOlNs34 by https://journals.lww.com/rapm from Downloaded Congress 2018: E-Poster Viewing Abstracts Downloaded Background and Aims: Deviation of the spinal needle leads to technical dif- from ESRA8-0027 ficulties and can cause neurological complications. The aims of this study are, https://journals.lww.com/rapm E-POSTER VIEWING first, to verify in clinical conditions the results from in vitro studies that the de- viation of the cutting type spinal needle depends on the mutual position of the CENTRAL NERVE BLOCKS bevels (its own and that of the introducer); and second, to compare the incidence of paresthesia with two accesses - median or paramedian. ≥ COMPARING RESISTANCE TO WATER FLOW BETWEEN Methods: 210 patients, aged 18 years, presented for elective surgery were in- TWO SPINAL NEEDLES cluded in a prospective randomised study. Spinal anesthesia in all patients was by performed in a lateral position with 88 mm 25G Quincke with 38 mm 20G in- 1ojZViL9JnKxduCRhL/CcUAdyL6WwH5REYdVcwxqSc9xlxx/plvdjx0D6qkdcm/unXYqc/pwzsZMkY20jLisd3HCPQMoaMFxd03QOXvy15geUE+CR4J9Wp+ug9E5C+r4spJuQLeaJ8i4wLCpNFrgQgvjevOlNs34 Al-Ani T. Queen Elizabeth University Hospital, Anaesthesia, Glasgow, United Kingdom. troducer at L2-3 or L3-4. Paresthesia and the number of attempts have been doc- Background and Aims: This study compares resistance to water flow be- umented. Patient Randomization is a web-based Mersenne Twister algorithm at  tween the newly introduced Pajunk Sprotte® NRFit 25G 90mm spinal needle a 1:1 allocation.  and our department previously used Vygon Whitacre 25G 90mm spinal needle. -
CAS Number Index
2334 CAS Number Index CAS # Page Name CAS # Page Name CAS # Page Name 50-00-0 905 Formaldehyde 56-81-5 967 Glycerol 61-90-5 1135 Leucine 50-02-2 596 Dexamethasone 56-85-9 963 Glutamine 62-44-2 1640 Phenacetin 50-06-6 1654 Phenobarbital 57-00-1 514 Creatine 62-46-4 1166 α-Lipoic acid 50-11-3 1288 Metharbital 57-22-7 2229 Vincristine 62-53-3 131 Aniline 50-12-4 1245 Mephenytoin 57-24-9 1950 Strychnine 62-73-7 626 Dichlorvos 50-23-7 1017 Hydrocortisone 57-27-2 1428 Morphine 63-05-8 127 Androstenedione 50-24-8 1739 Prednisolone 57-41-0 1672 Phenytoin 63-25-2 335 Carbaryl 50-29-3 569 DDT 57-42-1 1239 Meperidine 63-75-2 142 Arecoline 50-33-9 1666 Phenylbutazone 57-43-2 108 Amobarbital 64-04-0 1648 Phenethylamine 50-34-0 1770 Propantheline bromide 57-44-3 191 Barbital 64-13-1 1308 p-Methoxyamphetamine 50-35-1 2054 Thalidomide 57-47-6 1683 Physostigmine 64-17-5 784 Ethanol 50-36-2 497 Cocaine 57-53-4 1249 Meprobamate 64-18-6 909 Formic acid 50-37-3 1197 Lysergic acid diethylamide 57-55-6 1782 Propylene glycol 64-77-7 2104 Tolbutamide 50-44-2 1253 6-Mercaptopurine 57-66-9 1751 Probenecid 64-86-8 506 Colchicine 50-47-5 589 Desipramine 57-74-9 398 Chlordane 65-23-6 1802 Pyridoxine 50-48-6 103 Amitriptyline 57-92-1 1947 Streptomycin 65-29-2 931 Gallamine 50-49-7 1053 Imipramine 57-94-3 2179 Tubocurarine chloride 65-45-2 1888 Salicylamide 50-52-2 2071 Thioridazine 57-96-5 1966 Sulfinpyrazone 65-49-6 98 p-Aminosalicylic acid 50-53-3 426 Chlorpromazine 58-00-4 138 Apomorphine 66-76-2 632 Dicumarol 50-55-5 1841 Reserpine 58-05-9 1136 Leucovorin 66-79-5 -
15 May, 30 Villages Throughout the Country Theatre Performance For
9 April - 15 May, 30 villages throughout the country Theatre performance for children: “Let me tell you a secret about the environment” Children’s Theatre Centre, Skopje (Brvenica & Sedlarce, Mlado Nagorichane & Staro Nagorichane, Chegrane & Forino, Vasilevo & Dobreici, Vatasha & Sopot, Bistrica & Kravari, Gorno Orizari, Kochilari, Leskoec & Kosel, Mogorche & Dolno Kosovrasti, Konopnica & Mozhdivnjak, Negorci & Mrzenci, Orizari, Istibanje, Ratevo & Rusinovo, Veleshta & Dobovjan and Topolcani & Kanatlarci) 20 April - Friday, 11:00-13.00 EU InfoCentre, Skopje Launching Event of EU funded cartoons: “We love Europe” Business Solutions Europa 23 April - Monday, 10:30-11:30 EU InfoCentre Press Conference on the Europe Day celebration activities 25 April - Wednesday, 14:00-16:00 Aerodrom Municipality, Skopje Drawing competition: “Europe for all generations” European Movement, Aerodrom Municipality 27 April - Friday, 12:00-14:00 Kumanovo Municipality Panel discussion: “European integration from the economic and security perspective” European Movement 30 April - Monday, Secondary schools throughout the country Open classrooms for older generations Ministry of Education and Science 30 April - Monday, Secondary schools throughout the country Essay Competition: “Why is it cool to be old?” Ministry of Education and Science 30 April - Monday, 12:00-14:00 Bitola Municipality Panel discussion: “European integration from the local perspective” European Movement 4 May - Friday, 09:30-15:00 ”Sv. Kiril i Metodij” University, Skopje Gathering of universities -
MACEDONIAN FILM NEWS FILMS RELEASED 2017/2018 FEATURE DOCUMENTARIES SHORT ANIMATIONS - No.1 - FESTIVAL DE CANNES 8-19 MAY 2018
MACEDONIAN FILM NEWS FILMS RELEASED 2017/2018 FEATURE DOCUMENTARIES SHORT ANIMATIONS www.filmagency.gov.mk - No.1 - FESTIVAL DE CANNES 8-19 MAY 2018 Address: 8 Mart no.4 Tel: + 389 2 3224 100 E-mail: contact@filmagency.gov.mk, Official page: www.filmagency.gov.mk MACEDONIAN FILMS RELEASED 2017 / 2018 FEATURE FILMS - NATIONAL PRODUCTION ГОДИНА НА МАЈМУНОТ THE YEAR OF THE MONKEY Director: Vladimir Blazevski Producer: Darko Popov Screenwriter: Vladimir Blazevski A mild political satire about a peculiar friendship between a lonely chimpanzee and an Director of Photography: Dimo Popov impoverished zoo warden, The Year of the Monkey is set in an upside-down world stuck in Editor: Blagoja Nedelkovski RELEASED transition - as seen through the eyes of the chimp, who escapes the zoo to become a rebel Sound Designer: Sasho Kalan hero in the harsh environment of the Balkans. Music Composer: Aleksandar Pejovski Cast: Igor Angelov, Behreda Reshit, Marija Kohn, Faik Mefailovski, Elena Trajkovska, Chun Lajchi www.pankfilm.mk MK, RS, SI, XK | 2018 | 109' | DCP | Black Comedy | Produced by Punk Film (MK) Co-pro- pankfi[email protected] duced by Kiselo Dete (RS), Strup (SI), Infinity (XK) The activities of the Macedonian Film Agency in recent years have mainly been focussed on supporting the production of ВРАЌАЊЕ THE RETURN Director: Kastriot Abdyli films. Other activities have included the organisation of film Producer: Kastriot Abdyli This contemporary story takes place in a Balkan village where the old and the new, Screenwriter: Kastriot Abdyli Co-Writer: Isa Qosja the traditional and the modern, eastern and western, all intertwine. Ilir, a young Alba- RELEASED festivals and the promotion of Macedonian film at international Director of Photography: Vladimir nian man from Macedonia who migrated to France, has decided to marry a French festivals and events, as well as international cooperation and Samoilovski woman by the name of Sabine (perhaps out of love, but perhaps also to secure his Production Design: Zeni Ballazhi encouraging the development of film professionals. -
Mirogabalin: Could It Be the Next Generation Gabapentin Or Pregabalin? Jae-Yeon Kim1, Salahadin Abdi2, Billy Huh2, and Kyung-Hoon Kim1
Korean J Pain 2021;34(1):4-18 https://doi.org/10.3344/kjp.2021.34.1.4 pISSN 2005-9159 eISSN 2093-0569 Review Article Mirogabalin: could it be the next generation gabapentin or pregabalin? Jae-Yeon Kim1, Salahadin Abdi2, Billy Huh2, and Kyung-Hoon Kim1 1Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Yangsan, Korea 2Department of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Received November 30, 2020 Revised December 15, 2020 Except for carbamazepine for trigeminal neuralgia, gabapentinoid anticonvulsants Accepted December 22, 2020 have been the standard for the treatment of neuropathic pain. Pregabalin, which followed gabapentin, was developed with the benefit of rapid peak blood concen- Handling Editor: Francis S. Nahm tration and better bioavailability. Mirogabalin besylate (DS-5565, Tarlige®) shows greater sustained analgesia due to a high affinity to, and slow dissociation from, the Correspondence α2δ-1 subunits in the dorsal root ganglion (DRG). Additionally, it produces a lower Kyung-Hoon Kim level of central nervous system-specific adverse drug reactions (ADRs), due to a low Pain Clinic, Pusan National University affinity to, and rapid dissociation from, the α δ-2 subunits in the cerebellum. Maxi- Yangsan Hospital, 20 Geumo-ro, 2 mum plasma concentration is achieved in less than 1 hour, compared to 1 hour Mulgeum-eup, Yangsan 50612, Korea Tel: +82-55-360-1422 for pregabalin and 3 hours for gabapentin. The plasma protein binding is relatively Fax: +82-55-360-2149 low, at less than 25%. As with all gabapentinoids, it is also largely excreted via the E-mail: [email protected] kidneys in an unchanged form, and so the administration dose should also be ad- justed according to renal function. -
Cornell Alumni Magazine, NY, and Additional Mail C/O Public Affairs Records, 130 East Seneca St., Suite 400, Ithaca, NY 14850-4353
c1-c4CAMjf11 12/16/10 10:18 AM Page c1 January | February 2011 $6.00 Alumni Corne Magazine Ghost World Photos Bridge Ithaca’s Past and Present cornellalumnimagazine.com c1-c4CAMjf11 12/16/10 10:18 AM Page c2 001-001CAMjf11toc 12/17/10 10:35 AM Page 1 January / February 2011 Volume 113 Number 4 In This Issue Corne Alumni Magazine 4 2 From David Skorton Money matters 4 The Big Picture A big blow-up 6 Correspondence Suicide prevention 9 Letter from Ithaca Shirt off their backs 10 From the Hill Oh, the humanities! 14 Sports Wrestle mania 17 Authors It’s all right 24 Summer Programs and Sports Camps 20 40 Wines of the Finger Lakes Swedish Hill Cynthia Marie Port 54 Classifieds & Cornellians in Business 55 Alma Matters 58 Class Notes 95 Alumni Deaths 48 96 Cornelliana 42 Through a Glass, Darkly Conserving a conservatory? FRANKLIN CRAWFORD Urban renewal was kinder to Ithaca than to some Upstate cities, but over the past cen- Currents tury many stately buildings have still been lost—from Ezra Cornell’s Free Circulating Library to Alonzo Cornell’s mansion to the grand old Strand Theatre. In a series of photos recently exhibited at the History Center of Tompkins County, former visiting professor Mark Iwinski captures the ghostly images of bygone structures superimposed 20 Flour Power over what stands in their place. Often, it isn’t pretty. Milling the old-fashioned way Starry Nights 48 Vegging In Cosmic storyteller BETH SAULNIER Eat Different Promoting a plant-based diet When the Moosewood Restaurant served its first meal thirty-eight years ago this month, the owners were still trying to figure out how to run the steam table (and the entrée Learning Curve was two hours late). -
Western Corn Rootworm (Diabrotica Virgifera Virgifera Leconte) in Europe: Current Status and Sustainable Pest Management
insects Review Western Corn Rootworm (Diabrotica virgifera virgifera LeConte) in Europe: Current Status and Sustainable Pest Management Renata Bažok 1 , Darija Lemi´c 1 , Francesca Chiarini 2 and Lorenzo Furlan 2,* 1 Department for Agricultural Zoology, Faculty of Agriculture, University of Zagreb, Svetosimunska 25, 10000 Zagreb, Croatia; [email protected] (R.B.); [email protected] (D.L.) 2 Veneto Agricoltura, Agricultural Research Department, 35020 Legnaro, PD, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-049-829-3879 Simple Summary: Diabrotica virgifera virgifera, also known as western corn rootworm (WCR), is a maize-specific pest that has been a serious threat in Europe since the mid-1990s. Between 1995 and 2010, European countries were involved in international projects to plan pest control strategies. However, since 2011, collaborative efforts have declined and the overview of knowledge on WCR is in great need of updating. Therefore, a review of scientific papers published between 2008 and 2020, in addition to direct interviews with experts responsible for WCR management in several European countries, was conducted to (1) summarize the research conducted over the last 12 years and (2) describe the current WCR distribution and population in the EU, and the management strategies implemented. A considerable amount of new knowledge has been gained over the last 12 years, which has contributed to the development of pest management strategies applicable in EU agricultural systems. There is no EU country reporting economic damage on a large scale. In many countries, solutions based on crop rotation are regularly implemented, avoiding insecticide Citation: Bažok, R.; Lemi´c,D.; use. -
Macedonian Films 2016/2017
MACEDONIAN FILMS 2016/2017 Through its activities over the years, the Macedonian success is yet further confirmation of the efforts of the Macedonian Film Agency, which are directed Film Agency has striven to provide comprehensive towards collaborations and partnerships in the interest of creating quality film projects that will funding for the Macedonian film industry and helped be worthy representatives of Macedonian cinematography. In the interests of promoting the latest to further develop and stimulate film production, film production, the Cannes Film Festival - Marche du film will traditionally host screenings of the international co-productions, film distribution, cinema following upcoming Macedonian films: The Year of the Monkey by Vladimir Blazevski (MK/RS/SI/ networks and film festivals, as well as encouraging the XK), Secret Ingredient by Gjorce Stavreski (MK/GR), and When the Day Had No Name by Teona writing of scripts, promoting the professional education Strugar Mitevska (MK/SI/BE) - a film which entered the official programme of this year’s Berlin of film professionals and promoting Macedonian International Film Festival. cinematography at renowned international film festivals and events by offering favourable conditions We hope that the projects presented on the following pages will attract your attention by offering a to foreign producers, thereby also promoting the Republic of Macedonia as a filming location. unique insight into Macedonian cinematography, Macedonian film professionals and the possibilities The Film Production -
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
US 20190192440A1 (19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2019 /0192440 A1 LI (43 ) Pub . Date : Jun . 27 , 2019 ( 54 ) ORAL DRUG DOSAGE FORM COMPRISING Publication Classification DRUG IN THE FORM OF NANOPARTICLES (51 ) Int . CI. A61K 9 / 20 (2006 .01 ) ( 71 ) Applicant: Triastek , Inc. , Nanjing ( CN ) A61K 9 /00 ( 2006 . 01) A61K 31/ 192 ( 2006 .01 ) (72 ) Inventor : Xiaoling LI , Dublin , CA (US ) A61K 9 / 24 ( 2006 .01 ) ( 52 ) U . S . CI. ( 21 ) Appl. No. : 16 /289 ,499 CPC . .. .. A61K 9 /2031 (2013 . 01 ) ; A61K 9 /0065 ( 22 ) Filed : Feb . 28 , 2019 (2013 .01 ) ; A61K 9 / 209 ( 2013 .01 ) ; A61K 9 /2027 ( 2013 .01 ) ; A61K 31/ 192 ( 2013. 01 ) ; Related U . S . Application Data A61K 9 /2072 ( 2013 .01 ) (63 ) Continuation of application No. 16 /028 ,305 , filed on Jul. 5 , 2018 , now Pat . No . 10 , 258 ,575 , which is a (57 ) ABSTRACT continuation of application No . 15 / 173 ,596 , filed on The present disclosure provides a stable solid pharmaceuti Jun . 3 , 2016 . cal dosage form for oral administration . The dosage form (60 ) Provisional application No . 62 /313 ,092 , filed on Mar. includes a substrate that forms at least one compartment and 24 , 2016 , provisional application No . 62 / 296 , 087 , a drug content loaded into the compartment. The dosage filed on Feb . 17 , 2016 , provisional application No . form is so designed that the active pharmaceutical ingredient 62 / 170, 645 , filed on Jun . 3 , 2015 . of the drug content is released in a controlled manner. Patent Application Publication Jun . 27 , 2019 Sheet 1 of 20 US 2019 /0192440 A1 FIG .